Skip to main content
Log in

Klassifikation gastroenteropankreatischer neuroendokriner Tumoren

Classification of gastro-entero-pancreatic neuroendocrine tumors

Der Radiologe Aims and scope Submit manuscript

Cite this article

Zusammenfassung

Tumoren des disseminierten/diffusen neuroendokrinen Systems sind durch einen gemeinsamen Phänotyp gekennzeichnet. In ihrer Biologie unterscheiden sich neuroendokrine Tumoren (NET) jedoch bzgl. Morphologie, endokrinologischer Symptomatik und Ursprungsorgan. Die WHO-Klassifikation trägt diesen Unterschieden Rechnung und klassifiziert NET nach einem einheitlichen Vorgehen, wobei die Parameter Größe und Invasionstiefe je nach Ursprungsorgan variieren. Um die Nomenklatur weiter zu vereinheitlichen, wurde vor kurzem von der „European Neuroendocrine Tumor Society“ (ENETS) der Vorschlag einer TNM-Stadien-Einteilung und Graduierung gastroenteropankreatischer NET vorgelegt.

Abstract

Tumors of the disseminated/diffuse neuroendocrine system (NET) are characterized by a common phenotype. However, the biology varies according to histomorphology, endocrine symptoms and organ of origin. The WHO classification takes these differences into account and uses a common framework, where the parameters size and extent of invasion vary according to the organ of origin. In order to achieve a further standardization of reporting the European Neuroendocrine Tumor Society (ENETS) recently proposed a tumor-node-metastasis (TNM) staging and grading system for gastro-entero-pancreatic NET.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Abb. 1
Abb. 2

Literatur

  1. Anlauf M et al (2007) Hereditary neuroendocrine tumors of the gastroenteropancreatic system. Virchows Arch 451 [suppl 1]:S29–S38

    Google Scholar 

  2. Anlauf M et al (2006) Sporadic versus hereditary gastrinomas of the duodenum and pancreas: distinct clinico-pathological and epidemiological features. World J Gastroenterol 12(34):5440–5446

    PubMed  Google Scholar 

  3. Burke AP et al (1997) Carcinoids of the jejunum and ileum: an immunohistochemical and clinicopathologic study of 167 cases. Cancer 79(6):1086–1093

    Article  PubMed  CAS  Google Scholar 

  4. Capella C et al (1995) Revised classification of neuroendocrine tumours of the lung, pancreas and gut. Virchows Arch 425(6):547–560

    Article  PubMed  CAS  Google Scholar 

  5. De Herder WW, O’Toole D et al (2006) ENETS consensus guidelines for the management of patients with digestive neuroendocrine tumors. Part 1 – Stomach, Duodenum and Pancreas. Neuroendocrinology 84(1)

  6. De Herder WW, O’Toole D et al (2008) ENETS consensus guidelines for the diagnosis and treatment of neuroendocrine gastrointestinal tumors. Part 2 – midgut and hindgut tumors. Neuroendocrinology 87(1)

  7. DeLellis R et al (2004) Pathology and genetics of tumours of endocrine organs. World Health Organization classification of tumours. IARC Press, Lyon

  8. Gosset A, Masson P (1914) Tumeurs endocrines de l’appendice. Presse Med 25:237–240

    Google Scholar 

  9. Grimelius L, Hultquist GT, Stenkvist B (1975) Cytological differentiation of asymptomatic pancreatic islet cell tumours in autopsy material. Virchows Arch A Pathol Anat Histol 365(4):275–288

    Article  PubMed  CAS  Google Scholar 

  10. Heitz P, Komminoth P et al (2004) Tumours of the endocrine pankreas. In: DeLellis R, Heintz P, Lloyd R, Eng C (eds) Pathology and genetics of tumours of endocrine organs. WHO classification of tumours, chapter 4. IARC Press, Lyon

  11. Hemminki K, Li X (2001) Incidence trends and risk factors of carcinoid tumors: a nationwide epidemiologic study from Sweden. Cancer 92(8):2204–2210

    Article  PubMed  CAS  Google Scholar 

  12. Jensen RT et al (2006) Well-differentiated duodenal tumor/carcinoma (excluding gastrinomas). Neuroendocrinology 84(3):165–172

    Article  PubMed  CAS  Google Scholar 

  13. Kimura W, Kuroda A, Morioka Y (1991) Clinical pathology of endocrine tumors of the pancreas. Analysis of autopsy cases. Dig Dis Sci 36(7):933–942

    Article  PubMed  CAS  Google Scholar 

  14. Marshall JB, Bodnarchuk G (1993) Carcinoid tumors of the gut. Our experience over three decades and review of the literature. J Clin Gastroenterol 16(2):123–129

    Article  PubMed  CAS  Google Scholar 

  15. Modlin IM, Lye KD, Kidd M (2003) A 5-decade analysis of 13,715 carcinoid tumors. Cancer 97(4):934–959

    Article  PubMed  Google Scholar 

  16. Modlin IM et al (2008) Gastroenteropancreatic neuroendocrine tumours. Lancet Oncol 9(1):61–72

    Article  PubMed  CAS  Google Scholar 

  17. Moldow RE, Connelly RR (1968) Epidemiology of pancreatic cancer in connecticut. Gastroenterology 55(6):677–686

    PubMed  CAS  Google Scholar 

  18. Oberndorfer S (1907) Karzinoide Tumoren des Dünndarms. Frankf Z Pathol 1:426–432

    Google Scholar 

  19. Peck JJ et al (1983) Carcinoid tumors of the ileum. Am J Surg 146(1):124–132

    Article  PubMed  CAS  Google Scholar 

  20. Ramage JK et al (2008) Consensus guidelines for the management of patients with digestive neuroendocrine tumours: well-differentiated colon and rectum tumour/carcinoma. Neuroendocrinology 87(1):31–39

    Article  PubMed  CAS  Google Scholar 

  21. Rindi G et al (1999) ECL cell tumor and poorly differentiated endocrine carcinoma of the stomach: prognostic evaluation by pathological analysis. Gastroenterology 116(3):532–542

    Article  PubMed  CAS  Google Scholar 

  22. Rindi G et al (2006) TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system. Virchows Arch 449(4):395–401

    Article  PubMed  CAS  Google Scholar 

  23. Rindi G et al (2007) TNM staging of midgut and hindgut (neuro) endocrine tumors: a consensus proposal including a grading system. Virchows Arch 451(4):757–762

    Article  PubMed  CAS  Google Scholar 

  24. Schmitt AM et al (2007) WHO 2004 criteria and CK19 are reliable prognostic markers in pancreatic endocrine tumors. Am J Surg Pathol 31(11):1677–1682

    Article  PubMed  Google Scholar 

  25. Service FJ et al (1976) Insulinoma: clinical and diagnostic features of 60 consecutive cases. Mayo Clin Proc 51(7):417–429

    PubMed  CAS  Google Scholar 

  26. Stinner B et al (1996) Surgical management for carcinoid tumors of small bowel, appendix, colon and rectum. World J Surg 20(2):183–188

    Article  PubMed  CAS  Google Scholar 

  27. Williams ED, Sandler M (1963) The classification of carcinoid tumours. Lancet 1(7275):238–239

    Article  PubMed  CAS  Google Scholar 

Download references

Interessenkonflikt

Der korrespondierende Autor gibt an, dass kein Interessenkonflikt besteht.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to A. Perren.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Perren, A., Schmitt, A., Komminoth, P. et al. Klassifikation gastroenteropankreatischer neuroendokriner Tumoren. Radiologe 49, 198–205 (2009). https://doi.org/10.1007/s00117-008-1781-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00117-008-1781-z

Schlüsselwörter

Keywords

Navigation